Contemporary cost-effectiveness analysis comparing sequential bacillus Calmette-Guerin and electromotive mitomycin versus bacillus Calmette-Guerin alone for patients with high-risk non–muscle-invasive bladder cancer

By Bachir Bassel G.   Dragomir Alice   Aprikian Armen G.   Tanguay Simon   Fairey Adrian   Kulkarni Girish S.   Breau Rodney H.   Black Peter C.   Kassouf Wassim  

Cancer, Vol. 120, Iss. 16, 2014-08 ,pp. : 2424-2431

Blackwell Publishing

Access to resources Recommend Favorite

Intravesical Bacillus Calmette-Guerin (BCG)--A Survey of Practice Patterns of Urologists Across Britain and Ireland

By Basu S.   Biyani C.S.   Puri R.   Prescott S.  

UroOncology, Vol. 3, Iss. 3-4, 2003-01 ,pp. : 115-119

Ashgate Publishing Ltd

Access to resources Recommend Favorite

The Effects of Intravesical Chemoimmunotherapy with Gemcitabine and Bacillus Calmette–Guérin in Superficial Bladder Cancer: a Preliminary Study

By Cho DY   Bae JH   Moon DG   Cheon J   Lee JG   Kim JJ   Yoon DK   Park HS  

The Journal of International Medical Research, Vol. 37, Iss. 6, 2009-11 ,pp. : 1823-1830

Field House Publishing

Access to resources Recommend Favorite

Intravesical therapy for bladder cancer

By Williams Steve K   Hoenig David M   Ghavamian Reza   Soloway Mark  

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 6, 2010-04 ,pp. : 947-958

Informa Healthcare

Access to resources Recommend Favorite

Intravesical Therapy of Superficial Bladder Cancer

By  

Current Pharmaceutical Design, Vol. 6, Iss. 3, 2000-02 ,pp. : 345-359

Bentham Science Publishers

Access to resources Recommend Favorite